Doltrex 50 mg FC tablet
PDF Leaflet Revision Date: 14 April 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Management of moderate to moderately severe pain.
Dosage (summary)
Adults: 50 mg initially, then 50-100 mg every 4-6 hours; max 400 mg/day.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy or breastfeeding.
Key Drug Interactions
- MAO inhibitors
- Centrally depressant medicines
- SSRIs and SNRIs
Contraindications
- Hypersensitivity to tramadol
- Acute intoxication with alcohol or opioids
- Severe respiratory depression
- Epilepsy
Common side effects
- Dizziness
- Nausea
- Constipation
- Fatigue
Counselling Points
- Take whole with liquid, not chewed.
- Avoid alcohol and CNS depressants.
- Monitor for signs of respiratory depression.
Serious warnings
- Risk of seizures
- Potential for dependence
- Respiratory depression
Important Disclaimer
The Doltrex 50 mg FC tablet professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
